Uncategorized
Thank you for visiting DiaPharma at AASLD The Liver Meeting®
It’s Not Just Support. It’s Solutions.
THANK YOU FOR VISITING DIAPHARMA
AT AASLD THE LIVER MEETING®!
We enjoyed speaking with you about MASH, ALD, MetALD, and DILI and the use of CK18/K18 M30® Apoptosense and M65® ELISAs as blood-based biomarkers for clinical research and drug trials at 2023 AASLD The Liver Meeting®.
Your Territory Manager will be reaching out to follow up on the specifics of the conversations we had and share more about the solutions we offer for your project.
Our team’s take aways from the meeting were mostly about the emphasis this year on Alcohol Associated Liver Disease (ALD) and microphysiological systems (MPS) for liver. We have watched the interest in both topics significantly grow over the years and are excited to have relevant solutions to offer in each area.
Learn more about our full portfolio of products for studying liver injury at diapharma.com.
For research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Celebrating 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01114Rev01
Thank you for connecting with DiaPharma at AABB 2023
It’s Not Just Support. It’s Solutions.
Thank you for connecting with us at AABB
We enjoyed seeing old friends and meeting new acquaintances at the AABB 2023 meeting. We had the opportunity to discuss the all-in-one Ceveron® s100* with ADAMTS13 Activity* in less than 30 minutes, along with new technology in platelet function measurement, featuring the T-TAS® 01 PL Assay and Atlas PST*. We also had the pleasure of introducing the Nu.Q® Discover H3.1* Research Use Only ELISA, the innovative, ready-to-run reagent-complete kit for profiling nucleosomes. On the anticoagulation side, we were excited to discuss our FDA-cleared chromogenic DiaPharma Factor X for warfarin monitoring when INRs are unreliable, along with our selection of anti-Xa assays.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Our team will be reaching out to provide specific product information. We invite you to connect with a DiaPharma scientist with any questions as well.
DiaPharma provides:
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Marker Assays
- Thromboinflammation Marker Assays
- NETosis Research Assays
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Biomarker assays for early detection of liver injury during AAV gene therapy trials
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01105Rev01
DiaPharma has a lot to share at The Liver Meeting® – come see us!
It’s Not Just Support. It’s Solutions.
VISIT DIAPHARMA
AT THE LIVER MEETING®!
We are looking forward to learning the latest expert insights about MASH, ALD, DILI, and introducing ourselves to metALD, at the 2023 AASLD The Liver Meeting®.
This is one of DiaPharma’s favorites for sharing information on our CK18/K18-M30® and CK18/K18-M65® ELISAs, blood-based biomarkers to measure liver injury of all types. CK18 is a hepatocyte death marker, used to understand disease activity, frequently used as a biomarker in a variety of drug development and drug trial scenarios. These non-invasive tests (NITs) are exploratory endpoints for early efficacy, and correlate with the ever-elusive ballooning cell.
Who is studying NETs related to liver? If you are, come and learn about Volition Nu.Q® Discover H3.1 Research Use Only ELISA, an innovative, ready-to-run complete solution to profiling nucleosomes.
Booth D3217 is where Team DiaPharma will be. We invite you to stop by and discuss these intriguing topics.
For research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Celebrating 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01108Rev01
DiaPharma now hiring QA / RA Manager
Quality Assurance & Regulatory Affairs Manager
DiaPharma Group, Inc. – West Chester, Ohio
Hybrid – three days per week onsite
DiaPharma Group specializes in laboratory assay kits, reagents, and instrumentation for research and clinical applications in the fields of coagulation, platelet function, bleeding and clotting disorders, cell death, liver injury, and oncology. We deliver solutions and support to our customers.
Our in vitro diagnostic test kits and instruments are used in hospital laboratories, clinical reference laboratories, universities, and pharmaceutical companies. Our line of research products is used by researchers and medical corporations for product development, clinical research studies, and in quality control laboratories.
We seek a seasoned Quality Assurance – Regulatory Affairs Manager to manage quality systems, processes, and procedures to assure product safety and quality. This individual will drive business alignment to correct industry requirements by managing quality system design, controls, and continuous improvement.
Key responsibilities include:
- Serve as Management Representative.
- Promote audit readiness, prepare company for inspections by external bodies, including FDA, Health Canada, and customers, and facilitate audits and inspections.
- Own and manage quality systems, processes, policies, and procedures to assure product quality and safety across the business.
- Engage strong intradepartmental and cross-functional/organizational relationships to drive Quality System Requirements (QSRs).
- Influence and track quality system metrics such as Corrective and Preventive Action, training metrics, and complaint resolution metrics.
- Ensure compliance to FDA and Health Canada regulations.
- Ensure/follow up/implement corrective actions that are raised by deviations, internal audit, or regulatory inspection.
- Spearhead and prepare regulatory submissions and perform regulatory activities, such as 510(k) and de novo submissions.
- Other duties as assigned.
Requirements include:
- Bachelor’s degree or higher.
- 3 to 5 years of experience working in the medical device industry, specifically in area of Quality Assurance and Regulatory Affairs.
- Experience with in vitro diagnostics (IVDs) a plus.
- Demonstrated knowledge of medical device quality system regulations (e.g. QSR, ISO 13485, MDSAP), including Design Control, DMRs/DHFs, CAPA, Complaints, Risk Management, Document Control, Training, Complaint Handling, and Audits.
- Ability to interface with top organizational leadership and internal and external customers, responding in a professional manner.
- Experience with the following:
- Preparing FDA submissions, license applications, registrations and other product approval documentation.
- Analytical & problem-solving skills/root-cause analysis.
We offer:
- A competitive salary.
- Generous PTO and paid holiday schedule.
- Abbreviated Friday schedule.
- Superior medical, dental, life, STD & LTD insurance.
- 401(k) participation with generous match.
- Supportive work environment.
- Continuing education and training opportunities.
* Benefits may be subject to eligibility requirements and waiting period.
DiaPharma Group, Inc., provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.
This employer participates in E-Verify.
For consideration, please forward your resume to employment@diapharma.com.
What’s New at DiaPharma? Ted Lasso said it best…
It’s Not Just Support. It’s Solutions.
Our Commitment to Be Curious
DiaPharma held our semiannual company-wide meeting this summer. On the work side, we channeled Ted Lasso in our commitment to be curious. We reaffirmed who we are: scientific support, solutions-based sales, accommodating customer service, and common-sense operations. One DiaPharma team, working together, to provide a helpful and personal experience so our customers accomplish their goals.
On the play side, we tried our hands at TopGolf and Pickleball, both of which were taken as seriously as our commitments in business. Congrats to Tom Boulden and Ryan McCaw, our Pickleball champs!
Meet us in person at the following events:
- Mayo Classical Hematology Conference: October 3 – 4 in Rochester, MN
- Mayo Bleeding and Thrombosing Diseases Conference and Workshop: October 4 – 6 in Rochester, MN
- Society for the Advancement of Patient Blood Management (SABM): October 4 – 7 in Nashville, TN
- Association for the Advancement of Blood and Biotherapies (AABB): October 13 -17 in Nashville, TN
- AASLD The Liver Meeting®: November 10 – 14 in Boston, MA
- American College of Rheumatology (ACR) Convergence: November 10 – 15 in San Diego, CA
- American Society of Hematology (ASH) Annual Meeting and Exposition: December 9 – 12 in San Diego, CA
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01102Rev01
Highest Quality Assays for IVIG and Albumin Safety Testing
Reliable testing for procoagulant contaminants
To reduce the risk of thromboembolic events, manufacturers need reliable assays to test procoagulant contaminants in IVIG and Albumin preparations.
DiaPharma offers a variety of products for sensitive quality control and safety testing for detection of potential thrombogenic activity.
Prekallikrein Activity Assays
Specialty Range of PKA Assay Kits, Reagents & Controls
Fractionation of Human plasma to produce Human Albumin and Immunoglobulin preparations can result in concentration of PKA. DiaPharma is excited to offer the highest quality PKA assay kits and reagents.
Featured Product: Human Prekallikrein Pool
- Save time and repeat runs with this ready to use, convenient, reproducible Human Prekallikrein Pool.
- Prepared according to the procedure recommended by the European Pharmacopoeia (EP) for assays of Prekallikrein Activator (PKA).
ROX FXIa
(110050)
Chromogenic kit for determination of low levels of FXIa in enriched or highly purified protein
- The most sensitive kit on the market
- Low interference – ideal for in-process and final testing of immunoglobulin preparations
- Reagents comprise highly purified components
Technothrombin TGA IVIG
(5006218)
Specially designed trigger reagent with phospholipid and tissue factor concentration optimized for IVIG preparation testing
Chromogenic substrates
S-2302 (S820340)
S-2366 (S821090)
|
S-2238 (S820324)
S-2288 (S820852)
|
All products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.
The DiaPharma team brings a deep knowledge base and strong technical expertise to every customer interaction. Questions about any product in our lineup? We’re just a click or phone call away.
800.526.5224 | info@diapharma.com | diapharma.com
ML-00-01095Rev01
8948 Beckett Rd 45069 West Chester US
Comprehensive Solutions for von Willebrand Disease Research
It’s Not Just Support. It’s Solutions.
Explore Assays from DiaPharma to Enhance Your
von Willebrand Disease Research
Reagent-complete kits for vWF Activity, Antigen, Collagen Binding, Propeptide, and more.
FEATURED PRODUCTS
- Collagen Binding ELISA
- Ask your Territory Manager about a free evaluation kit through September!
- Standardized Propeptide ELISA
- Ready-to-use complete kit
Ordering Info:
Product | Description | REF |
REAADS vWF Activity ELISA | vWF Activity | K10826 |
REAADS vWF Antigen ELISA | vWF Antigen | K034-001 |
TECHNOZYM® vWF:CBA ELISA* | vWF:CB | 5450301 |
TECHNOZYM® vWF:CBA Calibrator Set* | Calibrator | 5450310 |
TECHNOZYM® vWF:CBA Control Set* | Control | 5450312 |
TECHNOZYM® vWF:Ag ELISA Kit* | vWF Antigen | 5450201 |
TECHNOZYM® vWF:Ag Calibrator Set* | Calibrator | 5450210 |
TECHNOZYM® vWF:Ag Control Set* | Control | 5450212 |
Inter Array vWFpp ELISA* | vWF propeptide (vWFpp) Antigen | 13.2.095.0096 |
T-TAS® 01 | Microfluidic Clot Occlusion Instrument | 18001 |
Coamatic® Factor VIII | Chromogenic Factor VIII | K822585 |
Coatest® SP Factor VIII | Chromogenic Factor VIII | K824086 |
Coatest® SP4 Factor VIII | Chromogenic Factor VIII | K824094 |
Rox Factor VIII* | Chromogenic Factor VIII | 800070 |
Technochrom® Factor VIII* | Chromogenic Factor VIII | 5344101 |
* For research use only. Not for use in diagnostic procedures.
DiaPharma specializes in clinical and research products for:
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise is just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01093Rev01
Clot Club #47
A REVIEW OF THE XXXVTH INTERNATIONAL SYMPOSIUM ON TECHNICAL INNOVATIONS IN LABORATORY HEMATOLOGY 2023 (ISLH 2023)
Comprehensive Solutions for Your Fibrinolysis Research
It’s Not Just Support. It’s Solutions.
Fibrinolysis Assays
from DiaPharma that will enhance your research
Whether you’re researching basic fibrinolysis mechanisms or investigating new potential thrombolytics, you need reliable, relevant tests. DiaPharma can help you select the right assays.
Featured Products:
Technoclone tPA Purified Protein
- Single chain tissue type plasminogen activator (human, recombinant),with activity at least 300,000 IU/mg.
Technozym® PAI-1 Actibind® ELISA
- Quantitative determination of active PAI-1 antigen in human plasma
- Plasmin-α-2-antiplasmin (PAP) complex ELISA
- Detect elevated levels in hyperfibrinolysis and thrombolytic research.
View our full portfolio at diapharma.com.
All products are for research use only in U.S. and Canada. Not for use in diagnostic procedures.
DiaPharma specializes in clinical and research products for:
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise is just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01096Rev01
Comprehensive Solutions for Anticoagulation Research
It’s Not Just Support. It’s Solutions.
Explore Assays from DiaPharma to Enhance Your Anticoagulation Research
Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays.
DOAC-STOP™ Tablets*
THE original DOAC eliminator
- Don’t be fooled by copies – DOAC-STOP™ is THE original DOAC neutralizer
- Effectively eliminate interference from DOACs in plasma to get accurate results
- Perform clotting assays on plasma containing DOACs in anticoagulant research
- Also available: DOAC-Stop™ L (liquid for dispersion in whole blood) and DOAC-Stop™ µ* (for pediatric and small sample sizes). Contact us for samples!
Inhibitor Tubes*
Simplify your laboratory’s research needs
- Inhibitor Tubes can be used to prepare known positive samples for clotting and chromogenic assays.
- Inhibitor Tubes provide a pre-determined quantity of a DOAC coagulation inhibitor for delivery to a blood, plasma or urine sample in a tube – an alternative to lyophilized normal plasmas
MORE FROM DIAPHARMA:
- High quality calibrators and controls for the reliable measurement of Apixaban ● Rivaroxaban ● Edoxaban ● Arixtra ● Dabigatran
- Chromogenic anti-Xa kits to measure measure Low Molecular Weight Heparin (LMWH), Unfractionated Heparin (UFH), and direct FXa inhibitors
- Coamatic® Heparin, Coatest® Heparin, and Technochrom anti-Xa* to suit your needs
*For research use only. Not for use in diagnostic procedures.
DiaPharma specializes in clinical and research products for:
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise is just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01086Rev01
Nothing but NETs…Introductory pricing for Nu.Q® Discover H3.1 ELISA Research Use Only Kit
It’s Not Just Support. It’s Solutions.
DiaPharma now offers the
Volition Nu.Q® Discover H3.1 ELISA
DiaPharma is excited to announce a new relationship with VolitionRx Ltd to provide the Nu.Q® Discover H3.1 ELISA in the U.S. and Canada.
Volition’s Nu.Q® Discover H3.1 ELISA Research Use Only kit detects quantitative levels of circulating intact nucleosomes containing Histone H3 in plasma. This kit is the first standardized, off-the-shelf, commercial option available for NETosis clinical research.
In honor of a successful and NET-focused ISTH 2023, ask us about our limited Nu.Q® Pricing offer available now through September.
This ready-to-use ELISA kit includes standards and requires no further assay development
The Nu.Q® Discover H3.1 ELISA Research Use Only kit is a powerful research tool for a wide range of research areas that study nucleosomes and neutrophil extracellular traps (NETs) such as:
- Coagulation
- Thromboinflammation
- Oncology
- Sepsis
- Auto-immune Diseases
- Neurodegenerative Diseases
- Inflammatory Disease
- NETopathies (neutrophil extracellular trap associated diseases)
- COVID-19
For Research Use Only. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01082Rev01
Thank You for connecting with DiaPharma at AACC – ADLM 2023
It’s Not Just Support. It’s Solutions.
THANK YOU FOR CONNECTING WITH US
AT ADLM (AACC) Clinical Lab Expo 2023
We enjoyed discussing the hottest topics in Coagulation, NETs, Neutrophil Elastase Activity testing, MMPs, the all-in-one Ceveron® s100*, and the latest technology in platelet function measurement, featuring the FDA-cleared T-TAS® 01 PL Assay.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
DiaPharma provides:
- Innovative solutions to profiling nucleosomes
- Neutrophil Elastase Assays
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Markers
- Thrombo-inflammation Markers
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Anti-Hemoglobin antibodies for Sickle Cell Disease research
- Biomarkers for early detection of liver injury during AAV gene therapy trials
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01083Rev01
Clot Club #44
THROMBOSIS AND HEMOSTASIS IN LIVER DISEASE AND KIDNEY DISEASE: A CALL FOR MORE RESEARCH
Thank you for connecting with DiaPharma at ISTH 2023
It’s Not Just Support. It’s Solutions.
Thank you for connecting with us at ISTH
We enjoyed seeing old friends and meeting new acquaintances at the ISTH 2023 Congress in Montréal last month. We learned the latest on all things bleeding & clotting, and had the opportunity to demonstrate the all-in-one Ceveron® s100* along with new technology in platelet function measurement, featuring the T-TAS® 01 and Atlas PST. We also had the pleasure of announcing our new relationship with Volition to provide the Nu.Q® Discover H3.1 ELISA to our North American friends.
Our team will be reaching out to provide specific product information. We invite you to connect with a DiaPharma scientist with any questions as well.
DiaPharma provides:
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Marker Assays
- Thrombo-inflammation Marker Assays
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Biomarker assays for early detection of liver injury during AAV gene therapy trials
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01079Rev01
Connect with DiaPharma at AACC 2023
It’s Not Just Support. It’s Solutions.
STOP BY OUR BOOTH 4047 TO CONNECT WITH US
AT AACC Clinical Lab Expo 2023
We would love to see old friends and meet new acquaintances at the AACC 2023 Clinical Lab Expo, July 25 – 2 – 27 in Anaheim.
Our team is eager to talk about the latest in Coagulation, NETs, Neutrophil Elastase Activity testing, MMPs, and more! Demo the all-in-one Ceveron® s100 along with new technology in platelet function measurement, featuring the Atlas PST* and the FDA-cleared T-TAS® 01.
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Talk with us about:
- Innovative solutions to profiling nucleosomes
- Neutrophil Elastase Assays
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Markers
- Thrombo-inflammation Markers
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Anti-Hemoglobin antibodies for Sickle Cell Disease research
- Biomarkers for early detection of liver injury during AAV gene therapy trials
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01060Rev01
Gordon Research Conference (GRC) Cellular & Molecular Mechanisms of Toxicity (CMMT 2023)
DiaPharma is a proud to support the 2023 Cellular & Molecular Mechanisms of Toxicity (CMMT) Gordon Research Conference (GRC).
Don’t Miss Out – Complimentary Webinar on Neutrophils in Sputum: Why Give a Spit?
It’s Not Just Support. It’s Solutions.
It’s Almost Here!
Neutrophils in Sputum:
Why Give a Spit?
Wednesday, July 12 at 11 a.m. EDT
Please join DiaPharma for a complimentary educational webinar on the benefits of using sputum samples to take an accurate picture of neutrophil-driven immune responses in the lung.
Speaker Neil Alexis, Ph.D. of UNC Chapel Hill will discuss:
- What are the advantages of sputum samples vs. other types of lung samples
such as BAL? - What makes a high-quality sputum sample?
- What can or should be measured in sputum?
- Induced vs. Spontaneous Sputum – key differences – time and place for each.
- Induced Sputum: “I heard it’s hard to do”… no, but it’s easy to do poorly.
- Novel Sputum method: Home collection with delayed lab processing – encouraging data.
- Intro to NELF- Nasal Epithelial Lining Fluid – a noninvasive method of sampling for chronic lung disease biomarkers
To register, visit diapharma.com.
DiaPharma is the US and Canadian distributor of the ProAxsis ProteaseTag® Active Neutrophil Elastase Immunoassay and is hosting this webinar to spotlight the importance of neutrophilic activity in the lung and the tools available to measure it. Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01065Rev01
Complimentary Webinar: Intro to Sputum and Nasal Epithelial Lining Fluid (nELF) Sampling
It’s Not Just Support. It’s Solutions.
Mucus throughout the lung and airway can provide insight into immune responses to different insults. Join DiaPharma and Dr. Neil Alexis on Wednesday, July 12 at 11 AM EDT to learn about sputum and nELF sampling methods and the value that can be gleamed from analyzing biomarkers in these fluids (or not so fluid if you are doing it right!).
Neil Alexis, PhD., Professor, Dept. of Pediatrics, Division of Allergy, Immunology and Rheumatology at UNC Chapel Hill’s Center for Environmental Medicine, Asthma and Lung Biology (CEMALB)
About the Speaker: Dr. Alexis’s research is focused on examining the underlying pathophysiologic mechanisms of pulmonary diseases such as asthma, COPD and CF. Specifically, he is interested in the immune response in the airways using induced sputum as a primary sampling tool for measuring cellular, biochemical and genetic outcomes in the airways of human subjects. Dr. Alexis also supervises a biorepository of over 750,000 human biospecimens that supports CEMALB investigators, UNC collaborators, industry sponsors, and external investigators.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01064Rev01
Relevant topic in a time of wildfire smoke: Neutrophils in Sputum – Webinar July 12th
It’s Not Just Support. It’s Solutions.
Complimentary Webinar
Neutrophils in Sputum:
Why Give a Spit?
Wednesday, July 12 at 11 a.m. EDT
Over this past week, many of us in the Midwest and East are experiencing terribly low air quality due to the Canadian wildfires. A webinar on assessing neutrophil activity in the lung therefore could not be more relevant.
Dr. Neil Alexis has performed much of the research behind the air quality ranges established in the US today. Along with striving to understand environmental exposures (e-cigarettes, wood fire, burn pits, ozone, etc.) on the healthy lung, he aims to understand how those insults contribute to triggers on a background of pulmonary disease.
Please join DiaPharma and Dr. Alexis for a webinar covering sampling methods to measure the activity of immune cells, particularly neutrophils, in the lung.
To register, visit diapharma.com.
Learn about DiaPharma’s portfolio of products for pulmonary research
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01063Rev01
Webinar Alert: Neutrophils in Sputum: Why Give a Spit?
It’s Not Just Support. It’s Solutions.
Complimentary Webinar
Neutrophils in Sputum:
Why Give a Spit?
Wednesday, July 12 at 11 a.m. EDT
Please join DiaPharma for a presentation on the benefits of using sputum samples to take an accurate picture of neutrophil-driven immune responses in the lung.
Speaker Neil Alexis, Ph.D. of UNC Chapel Hill will discuss:
- What are the advantages of sputum samples vs. other types of lung samples
such as BAL? - What makes a high-quality sputum sample?
- What can or should be measured in sputum?
- Induced vs. Spontaneous Sputum – key differences – time and place for each.
- Induced Sputum: “I heard it’s hard to do”… no, but it’s easy to do poorly.
- Novel Sputum method: Home collection with delayed lab processing – encouraging data.
- Intro to NELF- Nasal Epithelial Lining Fluid – a noninvasive method of sampling for chronic lung disease biomarkers
To register, visit diapharma.com.
DiaPharma is the US and Canadian distributor of the ProAxsis ProteaseTag® Active Neutrophil Elastase Immunoassay and is hosting this webinar to spotlight the importance of neutrophilic activity in the lung and the tools available to measure it.
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Learn more about DiaPharma’s portfolio of products for pulmonary research
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01058Rev01
Connect with DiaPharma at ISTH 2023
It’s Not Just Support. It’s Solutions.
STOP BY OUR BOOTH 1028 TO CONNECT WITH US AT ISTH 2023
We would love to see old friends and meet new acquaintances at the ISTH 2023 Congress, June 24 – 28 in Montréal. Our team is eager to talk all things bleeding & clotting, and demo the all-in-one Ceveron® s100* along with new technology in platelet function measurement.
We also invite you to our partner Technoclone’s Presentation Theatre, “A New Dawn in FVIII Inhibitor Testing” on Tuesday, June 27.
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Talk with us about:
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Markers
- Thrombo-inflammation Markers
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Biomarkers for early detection of liver injury during AAV gene therapy trials
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01052Rev01
Supporting International NASH Day
It’s Not Just Support. It’s Solutions.
DiaPharma supports International NASH Day 2023
June 8, 2023 is International NASH Day. NASH Day raises visibility and urgency around fatty liver disease and its more advanced form, non-alcoholic steatohepatitis (NASH).
Non-alcoholic fatty liver disease (NAFLD) and NASH have few outward symptoms, and patients are often undiagnosed. However, recognized risk factors that are associated with NASH include obesity, type 2 diabetes, and hyperlipidemia. There are currently no approved pharmacologic therapy options for treating NASH. Promoting visibility and improving early detection are important steps to reduce the global prevalence of this disease.
DiaPharma supports NASH drug development by offering noninvasive tests (NITs) for biomarkers like Cytokeratin 18 (CK18) that provide early, biologically plausible indications of changes in disease activity. We believe that the future is bright and that safe and effective treatment options are within reach, with many promising candidates on the horizon.
Visit DiaPharma and VLVbio™ in the Biotech Village at the EASL Congress™ 2023
June 21 – 24 in Vienna
DiaPharma offers additional non-invasive biomarker assays for NAFLD/NASH, AH, and DILI research. Incorporating these biomarkers into your research adds valuable information about changes in disease activity, which could decrease time and costs of studies. M30® and M65® Cytokeratin 18 (CK18) ELISAs, Intact Proinsulin, sCD163, L-FABP, and FGF-21 are just a few of the biomarker assays offered by DiaPharma to help your drug candidate move forward.
If you’d like to speak with an expert about which biomarker would be most useful for your project, call 800.447.3846 or email us today.
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01057Rev01
Webinar Alert: “The role of inflammation in the vicious vortex of bronchiectasis – is it time to re-evaluate?”
It’s Not Just Support. It’s Solutions.
Complimentary Webinar Alert!
Inflammation and Bronchiectasis
June 8th, 2023 at 10 am EDT
DiaPharma is always on the lookout for educational opportunities. Insmed is hosting an informative and interactive webinar from Dr. James Chalmers on inflammation and bronchiectasis on Thursday, June 8 at 10 am Eastern.
“The role of inflammation in the vicious vortex of bronchiectasis – is it time to re-evaluate?”
What: Insmed is hosting an educational and interactive webinar from Dr. James Chalmers on inflammation and bronchiectasis on Thursday, June 8 at 10 am Eastern.
Why: As someone interested in lung disease and biomarkers, DiaPharma thought this webinar might be of interest to you.
Details: Insmed has published some positive data with their brensocatib trial using the ProAxsis ProteaseTag® Active Neutrophil Elastase and Proteinase 3 Immunoassays, which are distributed in the US and Canada by DiaPharma.
Brensocatib is a drug being developed by Insmed for the treatment of bronchiectasis. Brensocatib may decrease the damaging effects of inflammatory diseases by inhibiting DPP1 and its activation of neutrophilic proteases, like neutrophil elastase and proteinase 3. Active Neutrophil Elastase can be measured to endotype for bronchiectasis research and is used in current trials as a biomarker for enrichment, mechanism, and efficacy.
So join us as we learn about the role of inflammation in bronchiectasis this Thursday!
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Learn more about DiaPharma’s complimentary portfolio of products for pulmonary research
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01056Rev01
International Society on Thrombosis and Haemostasis (ISTH) Congress 2023
DiaPharma will be exhibiting at ISTH and would love for you to stop by our booth. In addition to showing off the newest FDA cleared PL Chip test for Total Thrombus formation Analysis System (T-TAS®), we will be sharing details on the new technology entering the research market related to platelet function testing and special coag. Please contact us to connect with our DiaPharma team members or schedule an instrument demo.
American Diabetes Association 2023
DiaPharma has never been to ADA, but is excited to learn more about what biomarkers are important for diabetes research. We offer the Intact Proinsulin ELISA* from TECO Medical and we are interested to understand how it could be useful for T1D and T2D research or clinical trials. Please contact us to connect with our DiaPharma team members.
*For Research Use Only. Not for use in diagnostic procedures.
EASL – THE INTERNATIONAL LIVER CONGRESS™
The liver is DiaPharma’s wheelhouse so we encourage you to set up a meeting with us or our partners at VLVbio to discuss how their liver injury marker, CK18*, can be useful in NASH, alcohol-associated liver disease, and drug safety research. We are always interested in learning the latest and staying in touch with researchers and clinicians in the field. Please contact us to connect with our DiaPharma or VLVbio team members.
*For Research Use Only. Not for use in diagnostic procedures.
DiaPharma Celebrates hae day :-)
It’s Not Just Support. It’s Solutions.
May 16 is hae day 🙂
Join DiaPharma in raising awareness, step by step
The annual hae day 🙂 aims to raise awareness worldwide of HAE. Team DiaPharma is getting #Active4HAE! Join us by logging time spent on physical or well-being activities at haeday.org.
Read about emerging therapeutic targets for HAE at diapharma.com.
Explore Assays from DiaPharma for Gene Therapy and Cell Therapy Research in Rare Diseases
HEREDITARY ANGIOEDEMA (HAE)
- Chromogenic C1 Esterase Inhibitor (C1-INH) activity
- Easy, automatable, simple and fast assay for chromogenic determination of C1-INH activity in plasma or concentrates
- Technothrombin® TGA
- Ceveron®* for TGA and all-in-one coagulation analyzer
*For research use only. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01048Rev01
Collagen is tough (pun intended), make your life easier with these QuickZyme kits
It’s Not Just Support. It’s Solutions.
DiaPharma and QuickZyme Know Matrix Matters!
For tissues with lower collagen levels and high matrix effect, analyzing collagen is difficult. QuickZyme therefore developed an assay in which the matrix effect was neutralized to make total collagen analysis suited for more organs or imbedded tissue. The references below are based on the sensitive tissue collagen assay and is focused on use in the liver, but their methods are applicable to a variety of organs, including heart, lung, kidneys and embedded tissue samples.
QuickZymeTotal Collagen Kit – hydroxyproline detection method details:
- Compatible with many tissue digestion protocols
- Wide detection range for accurate quantitation
- Easy 2 hour protocol with no drying step
- Application available for low collagen organs and paraffin imbedded tissue
- Applicable to all species types
References:
van den Hoek AM, Verschuren L, Worms N, et al. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology. Cells. 2020;9(9):2014. Published 2020 Sep 1. doi:10.3390/cells9092014
van den Hoek AM, de Jong JCBC, Worms N, et al. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk. Metabolism. 2021;124:154873. doi:10.1016/j.metabol.2021.154873
Collagen assays available from QuickZyme Biosciences:
- QuickZyme Soluble collagen assay
- QuickZyme Total collagen assay
- QuickZyme Sensitive Tissue Collagen Assay
- QuickZyme Hydroxyproline assay
- QuickZyme Sensitive Tissue Hydroxyproline Assay
Make your life easier with these QuickZyme kits.
Research use only in the U.S. and Canada. Not for use in diagnostic procedures.
NAFLD/NASH |
ALD/AH |
DILI Research |
K18: M30®/M65® |
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01046Rev01Rev01
Why isn’t this being funded?! Product Grant Opportunity from DiaPharma
It’s Not Just Support. It’s Solutions.
Thoughts from HTRS 2023, and a Grant Opportunity
The HTRS 2023 Scientific Symposium gave new insights in hemostasis and thrombosis, from health justice initiatives to the latest in antiphospholipid antibody testing.
One thing that stood out was a focus on bleeding and clotting disorders in special populations such as pregnancy, pediatrics, Sickle Cell Disease, and bleeding disorders in women and girls. Addressing outcomes, assessing risk, and making sure patients have access to treatment are taking center stage.
Among the calls to action discussed during HTRS was the need to communicate and collaborate with colleagues. We need to improve awareness of platelet disorders, better characterize diagnosis and care, and better address the impacts of bleeding in women and girls.
DiaPharma cares about research benefiting underrepresented populations. We have decided to take a step and be part of this shift we’re seeing in the hemostasis field.
DiaPharma is now accepting research project proposals for a complementary T-TAS® 01 platelet function analyzer to study bleeding risk. We hope the award of a T-TAS® 01 analyzer helps further impactful research in our field.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
View our full portfolio of hemostasis and thrombosis assays, including vWF and ADAMTS13 panels, automated FXIII, APC Resistance, and unique antibodies for analysis of hemoglobinopathies, feto-maternal hemorrhage, and Rh incompatibility, at diapharma.com.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01045Rev01
Are your patients getting the proper level of anticoagulation?
It’s Not Just Support. It’s Solutions.
Measuring Warfarin in Patients with a Lupus Anticoagulant
At the recent HTRS 2023 Scientific Symposium, a lively discussion in a Plenary Session was presented titled, “Do We Dare to DOAC?” in which presenters debated the use of DOACs in patients with antiphospholipid antibody syndrome (aPS).
For an in-depth review, read our April Clot Club post, “Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?”
The topic brings up the questions:
- Do LA/aPS patients always get the best anticoagulation treatments?
- What are the options for monitoring a patient with the presence of a strong LA inhibitor, where INRs might be unreliable?
- What test can measure the effect of warfarin to help ensure the patient is in therapeutic range?
The chromogenic FX assay can be used here to measure % FX. Chromogenic FX activity levels have shown utility for monitoring warfarin therapy in patients where INR is unreliable, such as in aPS (Rosborough & Shepherd, 2004).
The DiaPharma Factor X Kit is accessible, FDA cleared, and offered by reference labs across the U.S.
Visit diapharma.com to learn more.
Monitoring warfarin is a delicate balance
Reference: Rosborough T.K., Shepherd M.F. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy. 2004;24(7):838–842.
View our full portfolio of hemostasis and thrombosis assays at diapharma.com.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-01-00014Rev01
American Thoracic Society (ATS) 2023
DiaPharma will be exhibiting at ATS for the first time and is excited to meet key stakeholders in the pulmonary space. We will be sharing details about the ProAxsis ProteaseTag® Active Neutrophil Elastase Immunoassay* for research and clinical trials along with QuickZyme MMP Activity* assays and collagen assays. With all of the inflammation and fibrosis happening in lung disease, we are hoping these are helpful tools to add to the drug development toolbox in the respiratory landscape. Please contact us to connect with our DiaPharma team members, Olivia Stricker and Tinu Adewole.
*For Research Use Only. Not for use in diagnostic procedures.
WHD 2023
Today, April 17, is World Hemophilia Day. This year’s theme is “Access for All: Prevention of bleeds as the global standard of care”. DiaPharma supports access to information, treatment, and care for all people with bleeding disorders. Learn more and take action at https://wfh.org/world-hemophilia-day/.
#WHD2023
#WorldHemophiliaDay
#Hemophilia
#AccessForAll
#LightItUpRed
ML-00-01043Rev01
Clot Club #40
SHOULD DIRECT ORAL ANTICOAGULANTS (DOAC) BE USED IN INDIVIDUALS WITH ANTIPHOSPHOLIPID SYNDROME (APS) VS LONG TERM WARFARIN TREATMENT?
Clot Club #39
WHY ISN’T THIS BEING FUNDED?! THOUGHTS FROM HTRS 2023, AND A GRANT OPPORTUNITY FROM DIAPHARMA
Connect with DiaPharma at AACR 2023
It’s Not Just Support. It’s Solutions.
Connect with DiaPharma
at AACR 2023
We are eager to connect with the cancer research community at AACR 2023, and discuss the latest advances in the field. If you’re heading to Orlando, reach out to us to talk about your projects, the hottest conference topics, or what you’d like to see from industry.
Learn more about DiaPharma’s portfolio of assays for anti-cancer drug development, including M30 Apoptosense® + M65® ELISAs to identify mechanism of cell death in anti-tumor drugs.
Ask us about our full line of oncology research products, including TK1, Osteopontin, Periostin, Noggin, Mac-2 Binding Protein.
New this year: DiaPharma now has a comprehensive portfolio of IQProducts antibodies for use in flow cytometry analyses.
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01039Rev01
XXXVIth International Symposium on Technical Innovations in Laboratory Hematology (ISLH)
DiaPharma will be exhibiting at ISLH and would love for you to stop by our booth. In addition to showing off the newest FDA cleared PL Chip test for Total Thrombus formation Analysis System (T-TAS®), we will be sharing details on the new technology entering the research market related to platelet function testing and special coag. Please contact us to connect with our DiaPharma team members or schedule an instrument demo.
Address Unmet Needs in Type 1 Diabetes Drug Development with These Biomarkers
It’s Not Just Support. It’s Solutions.
How can blood-based biomarkers enrich your Type 1 Diabetes (T1D) study population?
In individuals at high risk for Type 1 Diabetes (T1D), the presence of two or more islet auto-antibodies (AAs), such as those to insulin, GAD65, IA-2, and ZnT8, has been shown to be predictive of the rate of disease progression. These islet AAs can be used together with other features to help identify individuals at highest risk for disease development.
In trials intended to prevent or delay the clinical diagnosis of T1D, including these biomarkers in the enrollment process can therefore aid in enriching the study population with subjects likely to progress to stage 3 disease within a reasonable time span. This may allow for smaller and shorter trials, leading to potential cost savings for the study sponsors.
Leading Expertise in Type 1 Diabetes Research Assays
DiaPharma offers ELISAs from our partner Medipan GmbH for determination of islet AAs in human serum samples.
- Medizym® Anti- GAD (35071) – antibodies against glutamic decarboxylase (GAD65)
- Medizym® Anti- IA2 (35061) – antibodies against protein tyrosine phosphatase (insulinoma antigen-2, IA-2)
- Medizym® IAA (38061) – IgG antibodies against insulin
These quantitative assays are easy to perform, and provide reproducible and reliable results.
- Convenient: Ready-to-use, color- and barcoded reagents
- Incubation at room temperature
- Results expressed in IU/mL
- Excellent sensitivity and specificity
- High precision within the measurement range
- Fully automatable
Contact your territory manager for an introductory offer!
Also available exclusively in North America from DiaPharma, TECO® Intact Proinsulin ELISA – Go with the Pro! Save time and guess work by selectively measuring only intact proinsulin.
All products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01022Rev01
Digestive Disease Week (DDW)
DiaPharma has never been to DDW, but it seems like a place we should be since we have tons of unique biomarkers for research in the liver and diabetes. Please contact us to connect with our DiaPharma team members.
Visit DiaPharma at ATS 2023 to discuss pulmonary markers in drug development
It’s Not Just Support. It’s Solutions.
Visit Booth 1232 at ATS 2023
to discuss mechanistic measurements for respiratory drug development
ADD DETAIL to a drug’s storyline with accurate and lung-specific measurements of inflammation like neutrophil elastase (NE), proteinase 3 (PR3), collagen, and keratin 18.
DiaPharma offers consumable products that measure novel biomarkers and are aimed to add value, by adding info, for respiratory drugs in development. We’re excited to share these unique tools for your respiratory research. Stop by our booth to chat!
- Cystic Fibrosis
- COPD
- Bronchiectasis
- Asthma
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Learn more about DiaPharma’s complimentary portfolio of products for pulmonary research
It’s Not Just Support. It’s Solutions.
Celebrating 25 years of scientific expertise,
with support just a call or click away.
Copyright © 2023 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01033Rev01
Thank You for Visiting DiaPharma at HTRS 2023
It’s Not Just Support. It’s Solutions.
Thank you for connecting with us at HTRS 2023
The HTRS 2023 Scientific Symposium presented an opportunity to gain new insights in hemostasis and thrombosis, from health justice initiatives to lively and insightful debates (including apparently, how many steel mills there are in downtown Hamilton, Ontario).
Our DiaPharma team was pleased to speak with you about our testing solutions, including new technology in platelet function measurement. We hope you had a chance to enjoy some sun and fun as well!
Learn more about what DiaPharma has to offer:
T-TAS® 01 PL Assay: One test, one result, one answer for total platelet function. FDA cleared.
Atlas PST*: Discover a new dimension of platelet analysis. Uniquely measure platelet contractile forces to add data in a multitude of research applications.
View our full portfolio of hemostasis and thrombosis assays, including vWF and ADAMTS13 panels, at diapharma.com.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01030Rev01
Visit DiaPharma at ISLH 2023 in New Orleans
It’s Not Just Support. It’s Solutions.
Connect with Us at ISLH 2023
Booth 102
We would love to see old friends and meet new acquaintances at ISLH 2023, May 11 – 13 in New Orleans. Our team is eager to talk all things bleeding & clotting, and demo new technology in platelet function measurement.
Stop by to discuss:
- The latest platelet function testing solutions
- Coagulation + fibrinolysis markers
- Thrombo-inflammation markers
- Anticoagulation measurement kits and reagents
- Unique antibodies for analysis of hemoglobinopathies, feto maternal hemorrhage, and Rh incompatibility
- Do-it-all coagulation analyzers
- Hepatotoxicity biomarkers for early detection of liver injury
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01027Rev01
Visit DiaPharma at SOT ToxExpo 2023
It’s Not Just Support. It’s Solutions.
STOP BY BOOTH 1209 TO CONNECT WITH US AT SOT TOXEXPO 2023
See us in Music City! Visit us March 20 – 22 to learn the latest in toxicology and explore the music scene.
We’re eager to talk liver and kidney injury biomarker assays for detecting safety signals in drug development, including Keratin 18 (K18/CK18), L-FABP, α-GST, NGAL, and Cystatin C.
Or, just drop by to argue with us about the best music genre.
Let’s discuss K18 assays, including the M65® EpiRat ELISA to assess hepatocyte cell death in drug development
- Increased organ specific serum biomarker
- Quantifies hepatocyte cell death to assess liver toxicity
- Low day-to-day fluctuation and remarkably stable in serum
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01026Rev01
Visit DiaPharma at HTRS 2023 in Orlando
It’s Not Just Support. It’s Solutions.
STOP BY OUR BOOTH TO CONNECT WITH US AT HTRS 2023
We would love to see old friends and meet new acquaintances at HTRS 2023, March 10 – 12 in Orlando, FL. Our team is eager to talk all things bleeding & clotting, and demo new technology in platelet function measurement.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
Talk with us about:
- The latest platelet function testing solutions
- Coagulation + Fibrinolysis Markers
- Thrombo-inflammation Markers
- Anticoagulation Measurement Kits and Reagents
- Do-it-all Coagulation Analyzers
- Hepatotoxicity biomarkers for early detection of liver injury
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01016Rev01
Anticoagulation Forum 17th National Conference
Coag is DiaPharma’s wheelhouse so we are heading to the Anticoagulation Forum. We are always interested in learning the latest and staying in touch with researchers and clinicians in the field. Please contact us to connect with our DiaPharma team members.
View the recording of “Shearly You Can’t Be Serious! T-TAS® 01 for Total Platelet Function”
It’s Not Just Support. It’s Solutions.
Sorry you missed it! You can still view the recording.
Shearly you can’t be serious!
T-TAS® 01 for total platelet function
T-TAS® 01 PL Assay:
One test, one result, one answer for total platelet function
Talk to a DiaPharma scientist today to learn more.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-08-00052Rev01
Explore the Atlas PST – a New Dimension of Platelet Analysis
It’s Not Just Support. It’s Solutions.
Stasys Atlas PST
Easy system for fast, accurate platelet function results
- Designed to form microclots from whole blood samples to uniquely measure platelet contractile forces, aggregation, and function
- Fast (< 3 minutes) and accurate results mean more information for your platelet function research
- Reagents and agonists not needed – easy to bring in-house
Top: The Stasys proprietary sensor technology measures the force of a formed microclot on the cellular level, and rapidly evaluates factors in the blood to assess coagulopathy.
Bottom: As the sample moves through the analysis chamber, microclots form and the force of the bond is measured.
Quickly detect all mechanisms of platelet dysfunction
- Global assay of primary hemostasis measuring platelet clot strength
- User-friendly device with small footprint (~1 sq ft) – rapid and self-contained testing
- Minimal sample handling – no pipetting, no mixing
- Report real-time data in under three minutes
An individual sensor at the micron scale, and the shear gradients that it creates on passing streamlines of blood.
Add data in a multitude of research applications:
- Research and drug development of potential therapeutics to restore primary hemostasis in e.g. ECMO subjects, anti-vWF agents, etc.
- Bleeding risk / coagulopathy in trauma, sepsis, and DIC
- Acute thrombosis (e.g. subjects with coronary artery disease before/after intervention, PAD, COVID, cancer-associated thrombosis)
- Antiplatelet drug titration
- Hereditary platelet disorders
For research use only in the U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-10-00010Rev01
Thank you for attending “Shearly You Can’t Be Serious! T-TAS® 01 for Total Platelet Function”
It’s Not Just Support. It’s Solutions.
Thank you for attending
Shearly you can’t be serious!
T-TAS® 01 for total platelet function
T-TAS® 01 PL Assay:
One test, one result, one answer for total platelet function
Talk to a DiaPharma scientist today to learn more.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-08-00051Rev01
Hemostasis and Thrombosis Research Society (HTRS) 2023 Scientific Symposium
Schedule a demo for the T-TAS®01 system or the Stasys Atlas platelet analyzer* or just stop by the DiaPharma table to say hello. Please contact us to connect with our DiaPharma team members or schedule a demo.
*For Research Use Only. Not for use in diagnostic procedures.
Emerging Biomarkers in Alcohol Associated Liver Disease
It’s Not Just Support. It’s Solutions.
Non-Invasive Biomarkers for Alcohol Associated Liver Disease Studies
Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcohol Associated Liver Disease (ALD) and Alcohol Associated Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into:
- Disease severity and progression in ALD and AH research studies
- Mechanisms involved in ALD and AH pathogenesis
DiaPharma has the tools for ALD Research.
Measure hepatocyte apoptosis and/or necrosis with our Cytokeratin 18/Keratin 18 (CK18/K18) biomarkers:
- M30 Apoptosense® ccK18 ELISA
- Measures apoptosis
- M65® ELISA and M65® EpiDeath® K18 ELISA
- Measures total cell death
Additional Biomarkers of Interest:
- MMP Activity assays – MMP-2, MMP-8 and MMP-9 are potential markers of alcohol-associated liver cirrhosis
- WNT3A – marker of regeneration
- ERBB3 – levels are elevated during HCC
- Osteopontin (OPN) – important liver fibrosis and inflammatory biomarker
- Soluble CD163 (sCD163) – Macrophage-induced inflammation marker
- Complement Factors 3a/5a/C5b-9 – majority of complement components are produced in the liver and innate immune marker
- Total Collagen – measure total collagen in the liver without matrix effects
Also, ask us about the first commercial immunoassay kit to measure NETs in human plasma or serum on the market. Perfect for sepsis studies.
Visit diapharma.com for our comprehensive portfolio including biomarkers for Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH) and Drug Induced Liver Injury (DILI).
All products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise,
with support just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-01015Rev01
You name it, Ceveron® s100 can do it
It’s Not Just Support. It’s Solutions.
Discover the Ceveron® s100
The first fully-automated coagulation analyzer to combine classic technologies with high-powered LEDs for fluorescent and quenching resonance transfer assays. Perform clotting, chromogenic, and turbidometric hemostasis assays plus Thrombin Generation Testing, ADAMTS13 activity, and FXIII activity all with one instrument.
Why Ceveron® s100?
- Automate your FVIII, FXIII, C1-Inhibitor, ADAMTS13 activity, Thrombin Generation testing, and more
- Lot-stable calibration and ease of for on-demand testing
- Simultaneously run multiple assays and methods
Research use only in U.S. and Canada. Not for use in diagnostic procedures.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-07-00045Rev01
Axes, Rage, and VR at DiaPharma?
It’s Not Just Support. It’s Solutions.
Kicking off 2023
Axes, rage, and VR at DiaPharma? At our national sales meeting, there is!
DiaPharma held our national sales meeting in January – it’s a chance to see each other in person, plan the year ahead, and have some fun! DiaPharma staff tried our hands at axe throwing, virtual reality, and “rage room”. Congrats to customer service specialist Amy on her bullseye!
Meet us in person at the following events:
- Hemostasis and Thrombosis Research Society (HTRS) Scientific Symposium: March 10 – 12 in Orlando, FL
- Society of Toxicology (SOT) ToxExpo: March 20 – 22 in Nashville, TN
- Anticoagulation Forum: April 1 – 3 in San Francisco, CA
- American Association for Cancer Research (AACR): April 14 – 19 in Orlando, FL
- International Society for Laboratory Hematology (ISLH): May 11 – 13 in New Orleans, LA
- American Thoracic Society (ATS): May 19 – 24 in Washington, DC
- International Society for Thrombosis and Hemostasis (ISTH): June 24 – 28 in Montréal, Quebec
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
Copyright © 2022 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01012Rev01
Complimentary Webinar: “Shearly You Can’t Be Serious! T-TAS® 01 for Total Platelet Function”
It’s Not Just Support. It’s Solutions.
You’re invited to a complimentary webinar:
Shearly you can’t be serious!
T-TAS® 01 for total platelet function
T-TAS® 01 PL Assay:
One test, one result, one answer for total platelet function
Help address staffing and budgetary challenges with a frontline test for overall total platelet function
- Detects dysfunction due to anti-platelet therapy, and impaired primary hemostasis such as von Willebrand Disease (vWD)
- Activated by shear stress, not agonist
- Simultaneously handles multiple samples
- Useful and easy-to-interpret results
- Improve efficiency of additional testing
- Provide more information than a pathway-specific test
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-08-00049Rev01
Complimentary Webinar: “Shearly You Can’t Be Serious! T-TAS® 01 for Total Platelet Function”
It’s Not Just Support. It’s Solutions.
You’re invited to a complimentary webinar:
Shearly you can’t be serious!
T-TAS® 01 for total platelet function
T-TAS® 01 PL Assay:
One test, one result, one answer for total platelet function
Help address staffing and budgetary challenges with a frontline test for overall total platelet function
- Single assay with easy-to-interpret test result provides simple and comprehensive platelet reactivity status
- Get a better clinical picture using true physiological flow/shear rates
- T-TAS® 01 analyzer is low-cost, takes up modest space in the lab, and is uncomplicated to learn and operate
- Allows direct comparison of the effect of antiplatelet therapies across different combinations and classes (i.e. aspirin ± P2Y12 inhibitors)
It’s Not Just Support. It’s Solutions.
Over 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-08-00047Rev01
Clot Club #37
A STEEEEP LEARNING CURVE: MY TAKE HOME MESSAGES FROM AN ALCOHOL-ASSOCIATED LIVER DISEASE MEETING FROM A NEWBIE
Because matrix matters! The path to lung disease is paved with MMPs and collagen
It’s Not Just Support. It’s Solutions.
DiaPharma and QuickZyme Know Matrix Matters!
QuickZyme specializes in collagen assays and MMP activity assays (MMP-2, MMP-7, MMP-8, MMP-9, MMP-14). These assays were developed by scientists to fill an unmet need as an alternative to laborious methods. The assays give a more granular insight to the role that extracellular matrix remodeling can play in fibrosis, inflammation, and metastatic tumors.
MMPs degrade collagen, elastin, and proteoglycans. As indicators of inflammation and disease, they are key targets for drug development.
- Idiopathic pulmonary fibrosis (IPF): MMP-7 plays a role in the development of scarring in the lungs and may predict a decline of lung function.
- Chronic obstructive pulmonary disease (COPD): Circulating MMP-9 is linked with increased exacerbation risk.
- Cystic fibrosis (CF): MMP-7, MMP-8, and MMP-9 may play an important role in the injury/repair response in CF.
- Lymphangioleiomyomatosis (LAM): MMP-2 and MMP-7 are expressed and contribute to the destruction of lung tissue in LAM.
- Cigarette smoke: MMP-1, -2, -7, -9 and -12 have all been implicated in tissue damage due to cigarette smoke, but MMP-12 has been the most extensively studied.
Finally, a test to accurately and specifically quantify MMP activity in relevant biological samples (blood, sputum, urine, cell cultures, etc.). These kits make testing more efficient, with a dual readout option: Measure endogenous active (naturally occurring) or total (active + pro) MMP for each plate.
Make your life easier with these QuickZyme MMP Activity Assays:
- QuickZyme Human MMP-2 Activity Assay Kit
- QuickZyme Human MMP-7 Activity Assay Kit
- QuickZyme Human MMP-8 Activity Assay Kit
- QuickZyme Human MMP-9 Activity Assay Kit
- QuickZyme Mouse MMP-9 Activity Assay Kit
- QuickZyme Human MMP-14 Activity Assay Kit
Research use only in the U.S. and Canada. Not for use in diagnostic procedures.
More to Explore
DiaPharma offers an extensive portfolio of pulmonary biomarkers, including Cytokeratin 18 (CK18, K18) ELISAs – M30® and M65®, ProAxsis Neutrophil Elastase Activity Kit, IMD Neutrophil Elastase ELISA Kit, ProAxsis Proteinase 3 Activity Kit, IMD Proteinase 3 ELISA kit, Quickzyme Total Collagen Kit, IMD Alpha 1 Antitrypsin (A1AT), and IQ Macro163™ ELISA.
It’s Not Just Support. It’s Solutions.
Celebrating 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01000Rev01
Connect with DiaPharma at ASH 2022 in New Orleans
It’s Not Just Support. It’s Solutions.
SEE US AT ASH 2022!
DiaPharma continues to celebrate 25 years in the hemostasis and coagulation field – team members will be attending ASH 2022 in New Orleans this year. Our goal is to learn all the new things and meet up with existing and potential customers.
We’re interested in topics like:
- Gene therapy studies related to hemophilia, sickle cell disease, hereditary angioedema
- TMA updates and therapeutic strategies
- Platelet function related to thrombocytopenia
- Bleeding and clotting disorders
- Hemophilia diagnostics and treatment strategies
Reach out to Ryan McCaw or Elizabeth Mihal to set up a conversation about:
- ADAMTS13 assays for activity, antigen or inhibitor testing*
- The Total Thrombus formation Analysis System (T-TAS®) 01 for an IVD global platelet function test
- Chromogenic FVIII and FIX* activity testing
- HbS and HbF antibodies for flow cytometry
- The ATLAS PST* system for unique platelet function testing based on contractile force measurements and machine learning
*For research use only. Not for use in diagnostic procedures.
Our team is eager to talk all things bleeding & clotting, and demo new technology in platelet function measurement.
*Research use only in U.S. and Canada. Not for use in diagnostic procedures.
It’s Not Just Support. It’s Solutions.
Celebrating 25 years of scientific expertise, just a call or click away.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-00998Rev01
Tissue-Specific Biomarkers for Liver Injury in Gene Therapy Research
Studying liver toxicity in gene therapy research?
Emerging Exploratory Biomarkers for Drug Safety Studies
Improve Early DILI/DIKI Prediction Increased Tissue Specificity
|
|
ELISAs for Drug-Induced Liver Injury (DILI) |
||||
Biomarker | Sample Type | Description | Available Assay | Product # |
Keratin 18 (K18) | Serum or plasma | Highly specific biomarker for hepatocyte cell death (necrosis and apoptosis) |
Peviva M65® ELISA Peviva M65 EpiDeath® ELISA |
|
Caspase-cleaved Keratin 18 (ccK18) | Serum or plasma | Highly specific specific biomarker for hepatocyte apoptosis | Peviva M30 Apoptosense® | P10011 |
Osteopontin (OPN) | Serum or plasma | Biomarker for hepatic inflammation and necrosis |
Osteopontin Osteopontin N-Half |
|
Alpha Glutathione S-Transferase (a-GST) | Serum or plasma | Short half-life; sensitive to rapid changes in liver damage | TECO® Alpha GST | TE1056 |
Liver Fatty Acid Binding Protein (L-FABP, FABP1) | Serum or plasma | Sensitive marker for hepatic injury (leakage) | Diapharma L-FABP | DPGLFABP |
Research use only in the U.S. and Canada. Not for use in diagnostic procedures.
Over 20 years of scientific expertise,
with support just a call or click away.
Visit diapharma.com |
Diapharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
ML-00-00615Rev01
NASH-TAG (Therapeutic Agents for Non-Alcoholic Steatohepatitis and Liver Fibrosis) Conference 2019




Diapharma will attend NASH-TAG 2019 this year. Please click here to schedule a meeting with us or email us directly.
Learn from the leading researchers in NASH and Liver Fibrosis at NASH-TAG 2019
NASH-TAG = THERAPEUTIC AGENTS for NON-ALCOHOLIC STEATOHEPATITIS
About NASH-TAG
The NASH-TAG Conference is designed to bring together clinicians and researchers in academia and the pharmaceutical industry for a focused interactive educational update highlighting the most relevant advances and challenges in the diagnosis and therapy of NASH and liver fibrosis. NASH-TAG 2019 will take place over two days providing attendees an understanding of current and future directions in diagnostic procedures, prospects and challenges in drug discovery and development for both NASH and liver fibrosis. Internationally renowned faculty will assist in the development of the educational content and will serve as faculty at the conference.
NASH-TAG Topics will include
- MGL 3196 – a beta thyroid hormone receptor selective agonist
- Aramchol – SCD1 modulator
- NGM 282 – FGF19 construct
- GS 9674 FXR – second generation FXR agonist
- Selective PPAR modulators, hepatic and metabolic effects
- Interactive Dialog on NASH Topics
- Mitochrnodrial uncoupling as a pharmacological target in NASH
- Extracellular vesticles as mediators of inflammation
- Singnals form peclinical models and success of NASH trials
- 3D Trissue modeling and precision cut liver slices: Will they help drug testing for NASH?
- Barriers to overcome for reimbursement of NASH drugs
- Lessons learned fromt he reimbursement of diabetes and CV drugs
- Forecasting how the NASH market will develop in the US
- Pros in clinical trials of NASH
- Current and future trends in hepatic MRI using a background of cardiac MRI development
- Assessing DILI in NASH trials
- Genetic testing: Any use of sub phenotyping or risk stratification in clinical trials?
- Update from EASL & AASLD
- Understanding the methods of and need for CV risk assessment
- Second harmonic generation fully quantitative histopathology assessment for NASH
- GLP1R agonist compounds
- GLP1 – glucagon receptor dual agonists
- FGF21 – GLP1 dual agonism
- Integrin antgonism as an anti-fibrotoic therapy
- GPR40 and 84G cell coupled receptor modulators, BPI-4050
- P2x7 – puringergic receptor antagoist



NASH-TAG | Facebook | Twitter | LinkedIn | The Chateaux Deer Valley